Science Shop
Advertisement
FDA approves breakthrough gene therapies
In a groundbreaking development, the first-ever gene-editing drug for a genetic disease has been approved in the United States. Developed by Vertex Pharmaceuticals and CRISPR
Neuralink to Test Brain Chips on Humans
Neuralink, a company founded by Elon Musk, has received approval for a clinical trial of its Brain-Control Interface (BCI) with humans. The implant aims to
